Nilotinib versus imatinib for the treatment of patients with newly diagnosed chronic phase, Philadelphia chromosome-positive, chronic myeloid leukaemia: 24-month minimum follow-up of the phase 3 randomised ENESTnd trial
scientific article published on 17 August 2011
Author/s
author: Andreas Hochhaus, Richard A. Larson, Ian W. Flinn, Giuseppe Saglio, Hagop Kantarjian, Gianantonio Rosti, Rick E Blakesley, Leif Stenke, Carmino Antônio de Souza, Albert Hoenekopp
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.